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A Introduction
Protein kinases catalyse the transfer of the -phosphate group 20 of ATP onto serine, threonine or tyrosine residues of substrate proteins (Scheme 1). Phosphorylation can have profound effects on the phosphorylated protein, altering its enzymatic activity, ability to recognize and interact with other proteins, or subcellular localization. Phosphatases remove phosphoryl 25 groups, making phosphorylation a reversible modification. Consequentially, the balance of protein kinase and phosphatase activities controls the phosphorylation state of many, if not all, cellular proteins. Temporary perturbation of this balance when cells respond to stimuli is the basis for 30 protein kinase/phosphatase-mediated signal transduction. The identification of kinase-substrate interactions is central 35 to understanding phosphorylation-based. This task is complicated by the huge number of protein kinases and phosphorylated substrates involved. The human 'kinome' consists of 518 protein kinases and an estimated ~20,000 phosphorylation events. 1 The catalytic cores of kinases adopt 40 a common, conserved fold and mechanism to catalyse -phosphate transfer. This conservation complicates the identification of kinase-substrate pairs, because it makes it difficult to achieve selectivity for the -phosphate transfer reaction. In a cellular context, subcellular co-localization of a 45 kinase and its substrate(s), and long-distance interactions between the kinase and its substrate(s) facilitate control over the selectivity of a particular protein kinase. Some approaches, notably the use of labelled ATP analogues, require cells to be lysed, because of the membrane 50 impermeability of these hydrophilic molecules. Thus, the spatial control over kinase-substrate pairs is lost. For all these reasons faithful identification of all kinase-substrate pairs, especially those where the substrate is present at low abundance, is technically challenging. In this review we will 55 summarise methods to identify these kinase-substrate pairs. Emphasis will be given to recently-developed chemical genetic approaches, and the structural and enzymological basis of these approaches. In addition, we will also discuss activity-based profiling of active protein kinases that employ 60 chemical, ATP-based, probes for active protein kinases.
B Classical approaches towards identifying kinase-substrate pairs
Phosphorylation of potential substrates by a kinase is most often used to identify substrates for the kinase of interest. To identify substrates for a kinase, the kinase can be expressed in host cells such as bacteria, yeasts, or insect cells, and purified. The purified kinase can then be incubated with candidate 5 substrate proteins, chosen on the basis of current knowledge or candidate libraries, and an ATP molecule labelled at the -phosphate position. The -phosphate label often takes the form of a radioactive phosphate or a thiophosphate group, where the choice of label determines the strategy for detection 10 and isolation of the substrate(s). Candidate substrates can be provided as individual, recombinantly expressed and purified proteins. Substrates can also be supplied as libraries displayed on phages, arrayed as peptides or complete proteins on chips or microtiter plates, or even as whole cell lysates or lysates of 15 subcellular fractions. Successful phosphotransfer can then be demonstrated by a variety of methods such as autoradiography after gel electrophoresis or precipitation of the substrate and quantitative analysis of incorporated radioactivity by scintillation counting, followed by identification of the protein 20 by mass spectrometry (MS)-based methods. Expression of protein kinases is not always successful, necessitating purification and isolation of some kinases from cells or tissues. This, however, comes at the price of potentially introducing contaminating kinases into the assay. 25 This problem can be addressed if a given kinase has been expressed as a recombinant protein because quantitative comparison of -phosphate incorporation catalysed by wild type (WT) and a catalytically inactive mutant can be used to exclude phosphorylation events catalysed by contaminating 30 kinases.
Careful optimisation of the experimental conditions for -phosphate transfer, such as using high concentrations of recombinant kinase, -32 P-ATP of high specific activity, short incubation times, Mn 2+ instead of Mg 2+ as cofactor, and 35 chromatographic fractionation of the extract before the kinasing reaction, often allows successful identification of kinase substrates. Adoption of this careful optimisation of reaction conditions, together with parallel analysis of several isoforms of a kinase to identify substrates preferentially 40 phosphorylated by only one of the isoforms is the basis of the KESTREL method. 2 The major concern with in vitro identification of kinasesubstrate pairs is identification of a large number of falsepositive substrates, because the loss of tight control over the 45 kinases that is present in cells in vivo often leads to promiscuous substrate phosphorylation. [2] [3] [4] Other limitations, such as non-specific adsorption of proteins to chips or nitrocellulose membranes and incorrect folding of recombinant proteins also need to be considered. Furthermore, 50 for convenience, peptide analogues, rather than protein substrates, are often employed in in vitro studies, however, they often display K M values that are several orders of magnitude higher than their protein progenitors.
To identify kinase substrates in vivo substrates 55 phosphorylated by a given protein kinase in response to a stimulus can be identified by incubating cells with radioactive phosphate and comparing the spectrum of proteins that incorporated the radioactive phosphate in the presence and in the absence of the stimulus. This approach often suffers from 60 poor selectivity and the use of heroic amounts of radioactive phosphate. The use of phosphorylation-specific antibodies or phospho-specific binding domains 5 allows enrichment of phosphopeptides and thus limits the need to use high doses of radioactivity. Antibodies with high affinity and specificity 65 against phosphotyrosine are available, but preparation of antibodies of comparable quality against phosphoserine or phosphothreonine has been less successful. 3 All of these approaches require careful, case-specific optimisation and further validation, for example through in vitro kinase assays, 70 to ensure that substrates for the kinase of interest are genuinely identified. This is because activation of downstream kinases and secondary effects can easily lead to the identification of false positives. Identification of kinase substrates by in vivo phosphorylation of substrates in cells 75 treated with a protein kinase inhibitor often leads to false positive results because kinase inhibitors usually target conserved ATP-binding/catalytic sites in a promiscuous manner. 6, 7 Kinase-substrate pairs can also be identified by exploiting 80 the, often transient, interaction between the kinase and its substrate by any kind of methodology that allows studying of protein-protein interactions, such as pull-down assays, coimmunoprecipitation assays, cross-linking of kinase and substrate, yeast two-hybrid or split-ubiquitin assays.
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Interaction is not equivalent to phosphorylation, thus, substrates identified through interaction assays must be confirmed in phosphotransfer assays.
Instead of assaying for substrate phosphorylation, dephosphorylation of a phosphorylated substrate in the 90 presence of high ADP concentrations can also be used to identify a kinase substrate. 8 This approach exploits the principle that kinases, as catalysts, do not alter the equilibrium position of the phosphotransfer reaction and that, in consequence, the reaction can be drawn to the side of the 95 reactants by provision of a huge excess of ADP over ATP.
Genetic approaches
Genetic approaches can also be used to identify kinasesubstrate pairs. These approaches are most advanced for lower eukaryotes such as the yeast Saccharomyces cerevisiae.
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However, these organisms do not harbour the full spectrum of orthologues of mammalian kinases or their substrates, thus, many potential kinases and substrates of biomedical significance are, necessarily, 'missed' when these model organisms are used.
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In S. cerevisiae, synthetic genetic analysis (SGA) has been used to identify all pairwise genetic interactions between kinases, phosphatases, and their substrates 9 . SGA is based on robotic generation of mutant yeast cells that have two genes deleted, for example a kinase and its suspected (or known)
A common limitation of loss-of-function-based genetic approaches, such as SGA, is that gene pairs/families with redundant or overlapping functions escape investigation, plus it is limited to mutations that maintain viability of the cells. In addition, the mutant cells may adapt and mask the desired 5 phenotype. Redundant gene pairs/families can be studied using overexpression approaches, 10 but the level of overexpression of a protein or a functional enzyme itself may introduce artefacts into the experimental system. In addition, genetic approaches do not provide information on whether an 10 interaction is direct or indirect, in other words, mediated between the products of two interacting genes or by an unknown number of other proteins. The read-out of genetic interaction screens depends on the phenotype that is being investigated, meaning that many legitimate, but more subtle 15 interactions that do not affect growth may not be uncovered in a screen for growth defects at normal growth temperatures.
Despite their limitations, classical biochemical and genetic approaches have made, and will continue to make, valuable contributions towards identifying kinase-substrate pairs. To 20 obtain a complete picture of the kinome, the intrinsic shortcomings of classical approaches towards the identification of kinase-substrate pairs have to be addressed. Only then will reliable identification of all kinase-substrate pairs be possible, including the identification of those pairs 25 where one or both partners are present at low abundance. Chemical genetics of protein kinases promises to fill this gap. Protein kinase chemical genetics combines the genetic engineering of a protein kinase and chemical synthesis of ATP analogues tailored as substrates or inhibitors towards only the 30 engineered, or analogue-sensitised (as)-kinase, as it is known. This approach relies on our understanding of the mechanism of kinase-catalysed -phosphoryl group transfer from ATP onto substrates, binding of ATP to the active site, and synthetic strategies towards the preparation of ATP analogues. 35 In the following sections we will briefly review the structure and catalytic mechanism of protein kinases, then discuss synthetic strategies towards ATP analogues and limitations of as-kinases, before concluding with examples of other chemical methods for understanding protein-kinase-mediated 40 signalling pathways.
C Structure and catalytic mechanism of the protein kinase domain
The structures of the kinase domains of all eukaryotic protein kinases known to date are similar. This high degree of 45 sequence conservation suggests that all eukaryotic protein kinases share a common structure and use similar mechanisms to catalyse -phosphate transfer. 
Structure
A typical protein kinase domain consists of two lobes, a small N-terminal lobe (the N lobe), primarily involved in ATP binding, and a large C-terminal lobe (C lobe) that is largely responsible for substrate binding and catalysis ( Fig. 1) , with an additional role in ATP binding. Comparison of the X-ray structures of protein kinase A (PKA), the cyclin-dependent kinase CDK2, and the mitogen-activated protein kinase ERK2, reveals a largely conserved fold for both lobes. 4 The N lobe consists of a twisted five-stranded antiparallel -sheet and a lateral flanking C helix. The phosphate anchor 10 (GxGxxG, x = any amino acid) is located in a loop between sheets 1 and 2. Sheet 3 harbours an invariant lysine, K72, and the C helix provides the invariant glutamate, E91. The 'phosphate anchor' positions the -and -phosphates of ATP.
The C lobe consists of four  strands and several  helices. Its 15 important role in catalysis is illustrated by the presence of the 'catalytic loop' between 6 and 7 of PKA ( Fig. 1) N171, which binds a second Mg 2+ ion. Another important feature of the kinase domain is the activation loop. The activation loop is located between the last  strand and helix F. Certain protein kinases possess a conserved arginine immediately preceding the catalytic 25 aspartate (D166), a basic residue in strand 9, and basic residues in helix C. In these 'RD kinases' phosphorylation of serine, threonine, or tyrosine residues located in the activation loop induces positioning of the phosphorylated activation loop in to basic pockets. 12 Activation loop movement can also be 30 induced through interaction of the protein kinase with regulatory subunits, for example interaction of cyclindependent kinases with cyclins. 12 The activation loop gates access to the ATP or substrate binding pockets. Consequently, chemical probing for accessibility of the ATP binding pocket 35 can be used to identify the set of active kinases in a certain situation, for example in cancer cells 13 (cf. section E). Several residues interact with ATP, however, those contributing to recognition of the adenine portion of ATP and the catalytic core for phosphoryl transfer are of most 40 significance to chemical genetic studies and will be the primary focus here. Hydrogen bonds between the N7 nitrogen and the hydroxyl group of T183 and between the N6 nitrogen of the adenine ring and the backbone carbonyl of E121 bind the adenine ring in an otherwise hydrophobic pocket. L49, 45 V123, and a large hydrophobic residue, M121 in PKA, contribute to this hydrophobic pocket. Filling-in the space created in kinase mutants in which the bulky, hydrophobic M121 residue has been replaced by a smaller amino acid using chemically synthesised adenine nucleotide analogues carrying 50 a bulkier, hydrophobic adenine residue is the basis of protein kinase chemical genetics developed by Shokat and co-workers (Fig. 2) . 
Catalytic roles of conserved residues
The catalytic mechanism for -phosphate transfer is highly dissociative (Scheme 2) 11 , meaning that bond breaking between the leaving group O-atom and the -phosphorus atom 65 is more advanced than the formation of the bond between the O-atom of the incoming nucleophile and the -phosphorus atom in the transition structure. the -and -phosphates of ATP. It has been proposed to act as a Lewis acid stabilising the negative charge formed on the oxygen atom by bridging the -and -phosphates in the transition structure (Scheme 2B).
14 D166 forms a hydrogen bond with a hydroxyl group of an inhibitor peptide in crystal 10 structures of PKA, suggesting that D166 orients the hydroxyl group on the substrate for nucleophilic attack, 15 and subsequently acts as a general base that abstracts the proton from the hydroxyl group of the O-nucleophile late in the reaction 14 . The development of a large amount of negative 15 charge on the O-nucleophile at an early point along the reaction co-ordinate may actually hinder attack on the -phosphate because of charge repulsion between the (di)anionic -phosphate and the incoming nucleophile. 16 The cationic K168 makes an electrostatic contact with the -20 phosphate in PKA throughout the reaction, but is replaced by an arginine or even alanine in other protein kinases 17 . D184 is conserved in all kinases where it coordinates both Mg 2+ ions. A mutation of the analogous residue in the essential S. cerevisiae PKA isoform Tpk1p is incompatible with life, 25 suggesting that D184 is critical for enzymatic activity 18 . The cationic K72 contacts the -and -phosphates and its mutation to arginine or alanine does not affect K M,ATP , but decreases k cat up to 840-fold, highlighting the importance of this residue in catalysis. K72 may also be required for 30 formation of the active conformation by forming a salt bridge with E91 and sequestering E91 away from basic residues of the RD pocket.
D Chemical genetics of protein kinases
Chemical genetics of protein kinases has two aims: 19, 20 (i) to 35 identify the physiological functions of protein kinases, and (ii) to identify all substrates for a given protein kinase. The enlarged adenine binding site can be filled by providing an ATP analogue with a bulkier, hydrophobic adenine moiety. These ATP analogues can engage in 75 additional hydrophobic and van-der-Waals interactions with the enlarged adenine binding pocket and, thus, display an increased affinity for the as-kinase compared to ATP. At the same time, the bulkier heterocyclic ring systems preclude interaction of these ATP analogues with the ATP binding 80 pockets of most other endogenous protein kinases or adenine nucleotide utilising enzymes. For example, a series of enlarged adenine analogues (analogous to those outlined in Scheme 3) was found to have IC 50 Sandford's use of highly electron-deficient pyridine precursors illustrates the scope of sequential nucleophilic aromatic substitutions for the preparation of aza-heterocycles 35 ( Figure 3A) , 27 using chemistry that is sufficiently robust to be used in simple flow systems. 28 Recently, a mixture of organolithium, carbonyl and nucleophilic aromatic substitution methods has allowed automated, multistep synthesis of a small library of potential kinase inhibitors, 40 based on imidazo[1,2-b]pyridazines, using a microflow reactor ( Figure 3B) . 29 Taken together, these examples give a clear indication of the scope of simple, reliable chemical methods for the preparation of potential as-kinase inhibitors that can be used to selectively modulate the activities of 45 chosen kinases. The limiting factor in the application of these potential inhibitors is the ability to screen libraries of compounds to determine their inhibition characteristics and selectivity towards a given as-kinase system. However, the preparation of nucleotide triphosphates and their analogues is often a much more laborious task, even though clear, prescriptive procedures are available. 31 70 Usually, the assembly of ATP analogues can be broken down into two major disconnective steps; (i) preparation of the modified nucleoside, and (ii) elaboration to the triphosphate or its analogue (Scheme 5). These two conceptual steps will be considered in turn by way of a small 
Preparation of base-modified adenosine analogues
Routes to adenine analogues can be loosely categorised into three classes. Conceptually, the simplest approach employs Secondly, nucleophilic aromatic substitution of a leaving group from the C 6 -atom on an adenosine-based precursor, such as 6-chloropurine, by good nucleophiles is also a well- 20 established approach towards modification at the 6 position of the purine ring (Scheme 7). Finally, an adenine analogue can be assembled as a stand- 25 alone entity before being added to the ribose ring via a glycosylation procedure. For example, Shokat and co-workers have employed Hanefeld's pyrazolopyrimidine synthesis to assemble a series of adenine analogues which have then been glycosylated using a protected D-ribose system to generate (ii) NH3 in MeOH. 35 Once assembled, the adenosine system must be phosphorylated.
Phosphorylation
Whilst many procedures are available for the preparation of triphosphate analogues, 31, 34 we will focus on two widely 40 adopted approaches. In the first, a nucleoside diphosphate is assembled, then converted to the triphosphate analogue using enzymatic methods. In the second, a triphosphate is chemically ligated to a modifying group to generate the triphosphate analogue. 45 Diphosphates can be accessed by several routes, however, two commonly used routes will be discussed in detail here: (i) Yoshikawa phosphorylation of the modified adenosine followed by introduction of the second phosphoryl group through the use of tri-or tetraalkylammonium salts of 50 inorganic phosphate, and (ii) preparation of a 5´-tosylate of the adenosine analogue and subsequent displacement of this leaving group using a tri-or tetraalkylammonium salt of the inorganic pyrophosphate ion (Scheme 9).
When employing the Yoshikawa route, the adenosine 55 substrate must be dissolved in dry trialkyl phosphate solvent. Phosphorus oxychloride is then introduced in excess, often with a tertiary amine base that neutralises the acid that is evolved. 31 When following the Poulter route, 35 protection of the 2´/3´-cis-diol system of the adenosine substrate is usually 60 required in order to ensure exclusive 5´-tosylation, which adds protection and deprotection steps to this route. At this stage, both routes require sources of mono-or di-phosphate nucleophiles, which must be soluble in organic solvents. In order to overcome the intrinsic insolubility of metal salts of used to prepare tri-or tetraalkylammonium salts that show improved solubility in organic solvents. Preparation of the alkylammonium salts is a laborious task, however, some systems are commercially available. The mono-or diphosphate-sources must be scrupulously dry before addition 5 to the nucleoside-monophosphodichloridate intermediate or the 5´-tosylate, and this drying is achieved through timeconsuming repeated evaporations with dry pyridine.
Crude reaction mixtures from both procedures usually require extensive chromatographic purification. Crude 10 mixtures from the Poulter route are usually less complex, however, attempts towards the preparation of diphosphates via the Yoshikawa route often result in complex mixtures of mono-, di-and triphosphates that present a significant chromatographic challenge. 36 15 Other approaches towards the assembly of di-and triphosphates use phosphoramidates, such as morpholidates, 37 or carbonyl diimidazole (CDI) 38 as agents for the formation of phospho-anhydrides. There is usually a requirement for scrupulously dry conditions that must be maintained for long 20 reaction times. Furthermore, tri-or tetraalkylammonium salts of phosphates and careful, time-consuming chromatography steps are also needed, and, even then, these efforts are often poorly rewarded with moderate yields. 
Enzymatic labelling of the triphosphate group
Base-enlarged ATP analogues labelled with a - dissociation of the ADP by-product from the phosphorylated active site, the base-enlarged ADP substrate binds and the labelled phosphoryl group is then transferred to give the labelled, base-enlarged ATP analogue. 33 Immobilisation of NDPK on a solid support can be used to ensure that excess 40 labelled ATP donor and ADP by-product can be fully removed before introduction of the base-enlarged ATP analogue. It is essential to avoid the presence of ATP donor because this could be used by non-as-kinases and lead to false positives. 45 ATP analogues labelled with a - 23, 40 Subsequently, -32 P-based triphosphate analogues derived from Hanefeld's pyrazolpyrimidines (Scheme 8) have also been used. 33 -32 P-based systems have several disadvantages. Firstly, detection and isolation of labelled proteins requires the use of 2D gel methods. 55 Isoelectric focussing conditions in the first dimension have to be carefully chosen to minimize bias against highly acidic or basic proteins. Buffers to solubilize transmembrane proteins have to be carefully optimised to maximise solubility of these proteins in gel-based analysis systems. Secondly, 32 P-60 phosphorylated substrates are susceptible to hydrolysis by phosphatases, which decreases sensitivity and may introduce bias.
The use of chemically labelled -phosphates promises to circumvent some of these technical limitations. The most 65 obvious choice to label the -phosphate is replacement of one terminal oxygen atom by a sulfur atom in -S-ATP. The nucleophilic sulfur anion of the thiophosphate, when transferred to a substrate protein, offers a 'handle' for affinity purification, bioconjugation or, indeed, a combination of these 70 methods. Furthermore, thiophosphates are more resistant to hydrolysis by phosphatases, thus, once formed, thiophosphopeptides are more likely to be detected than phosphopeptides. In addition, -S-ATP is not readily accepted as a substrate by ATPases and adenine-enlarged -S-ATP 75 analogues can be generated with relative ease using NDPK as described above.
Simple reversible thiol affinity chromatography of systems that have been exposed to base-enlarged--S-ATP analogues, where captured thiophosphorylated peptides are released via 80 disulfide reduction, is limited by the fact that cysteinecontaining proteins are also likely to be captured. Judicious control of pH can be used to attenuate the reactivity of thiols in comparison to thiophosphates, 41 however, selective release of thiophosphorylated peptides from a capture resin represents 85 a more reliable strategy. This approach was adopted in parallel by Blethrow et al. and Chi et al. , who used different thiol-affinity resins and release strategies in order to accomplish this goal (Scheme 10). Blethrow et al. chose to capture both thiophosphorylated peptides and cysteine-90 containing peptides after digestion of a pool of potential substrates. 42 An iodoacetyl resin was employed, which led to the formation of carbon-sulfur bonds. In the case of the thiophosphate system, the resulting S-bridging phosphodiester was susceptible to hydrolysis after oxidation of the sulfur 95 10A). Chi et al. captured both thiophosphorylated peptides and cysteine-containing peptides after digestion, however, a thiopyridyl disulfide resin was employed in order to form mixed disulfides between the resin and thiophosphopeptides or cysteine-containing peptides. 43 The mixed disulfides 5 between simple thiols (on the resin) and thiophosphoryl groups are labile under basic conditions, however, simple mixed disulfides between resin and cysteine groups are not, thus, thiophosphopeptides were selectively eluted from the affinity resin (Scheme 10B). In a third approach, Allen et al. 10 chose to alkylate the nucleophilic thiophosphate ion and then used antibodies raised against an O-thiophosphorylated, Salkylated thiophospho-threonine-based hapten to immunoprecipitate thiophosphorylated, alkylated kinase substrates (Scheme 10C). 
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Scheme 10 Methods for selective purification of thiophosphorylated proteins and peptides. Green semi-circles represent thiophosphoproteins, green lines digested phosphoprotein fragments, red semi-circles non-thiophosphorylated proteins contained cysteine residues, red lines digested protein fragments derived from these proteins and cyan circles represent affinity matrices. Blue lines represent antibodies raised against S-(pnitrobenyl)thiophosphopeptides.
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Chemical labelling of the triphosphate group
Green and Pflum extended the use of -modified ATP analogues by using a -biotinyl-ATP 1 (Scheme 11A). 45 This approach relied upon the open nature of the active sites of many kinases around the position of the -phosphoryl group of 25 ATP (Fig. 1) . When -biotinyl-ATP 1 was incubated with protein kinase A or casein kinase 2 and their respective substrates, the biotinylated -phosphoryl group was transferred to the substrates in both cases (Scheme 11B). Once attached, the biotinyl group was used as an affinity tag for 30 purification of labelled substrates. The tag was then cleaved from the substrates using acid to allow for identification of the substrate by MS. The use of a phosphoramidate-linked label also gave conclusive evidence that significantly elaborated -phosphoryl groups can be transferred by kinases. This result is 35 initially surprising given the differenccs in mechanisms of phosphoryl group transfer between phosphate mono-and diesters. The fact that phosphoramidate-based -groups can be transferred can perhaps be explained by virtue of the fact that the -amino group is likely to be protonated at the pHs that are 40 used in labelling assays. This, in turn, probably leads to an increase in the electrophilicty of the adjacent phosphoryl group and a more dissociative mechanism for phosphoryl tranfer being retained, 46 with the net result being only minor reductions in observed k cat values (see dansyl systems below). In further extensions of this approach, Pflum and coworkers have developed ATP analogues with fluorophore-and photo-probe-modified -phosphoryl groups in the form of dansyl-and azido-phosphoramidates, respectively. 47, 48 The dansyl-ATP system was obtained commercially, whereas, the 10 azide was prepared via carbodiimide-based coupling of ATP to an amino-based linker connected to an aryl azide. With the dansyl system, efficient dansylation of both peptide and protein substrates was demonstrated where only relatively small reductions in k cat values (~6-25-fold) were observed. 15 With the azide system, a given kinase can transfer the azidemodified phosphoryl group to a substrate, then, when photolysed, the azide gives a reactive intermediate that can cross-link to the kinase. In this way, a covalent link can be established between a given kinase and its substrate(s) to form 20 a high molecular weight complex between the kinase and substrate which migrates as a single entity during gel electrophoresis. The substrate and kinase components can then be identified using classical blotting techniques. 47 Gouverneur and co-workers 49 have also developed 25 phosphoramidate-based azide-and alkyne--modified ATP analogues that can be used for 'click'-style cycloadditions and Staudinger ligations. These functional groups provide handles for further modification, such as addition of an affinity purification tag, when the -phosphoryl has been transferred 30 to a peptide substrate. Synthetic methods were based on CDI activation of ATP followed by reaction of the activated ATP with a functionalised amine. In addition, phosphoester-based, rather than phosphoramidate-based, systems were also explored, and these were prepared by sequential 35 phosphorylation of a functionalised alcohol followed by ligation of the resulting phosphate to ADP using CDI. Despite the expected difference in reactivity of the phosphoesterbased substrates, phosphorylation of p27 kip1 by CDK2 could be shown using an antibody against phosphorylated p27 kip1 .
49 40 Considering the tight steric requirements of the phosphospecific antibody during selective recognition of phosphorylated epitopes, these results are surprising and may require confirmation using more sensitive techniques, such as MS.
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Limitations of as-kinases
as-Kinases are powerful tools for identifying kinase substrates and the functions of protein kinases. The methodology is, however, limited by (i) mutation of the gatekeeper inactivating some protein kinases; (ii) a few kinases 50 possessing alanine or glycine as the gatekeeper amino acid, 50 (iii) provision of the as-kinase at endogenous expression levels, and as the sole source for the kinase; (iv) competition between ATP and adenine-enlarged ATP analogues in cell lysates as phosphate donors, (v) the membrane impermeability 55 of charged ATP analogues (vi) and the rapid hydrolysis and reincorporation of their labelled phosphates into nucleotides. Considerations (i), (ii) and (iii) affect the use of ATP analogues that lack transferable phosphoryl groups when trying to identify physiological functions of the as-kinase. 60 Limitation (i) is significant because loss of control over the time point of inactivation of the as-kinase by administration of the inhibitor largely eliminates the advantage that the use of as-kinases promises compared to classical approaches based on kinase-inactivating amino acid mutations. Limitation 65 (ii) indicates that interpretation of data arising from inhibition of as-kinases may not be foolproof.
Identification of so-called 'second-site suppressors' has gone some way towards addressing problems with as-kinases that do not tolerate mutation of the gatekeeper residue. 70 Mutation of the gatekeeper residue in G protein-coupled receptor kinase 2 (GRK2), cell division cycle 5 (cdc5) kinase, or MEK kinase 1 destroyed kinase activity. 40, 50 Nevertheless, the activity of these mutant kinases was restored by 'second site suppressor' mutations. These second-site suppressors can 75 be identified using random PCR mutagenesis screens ideally coupled to a phenotypical read-out in E. coli, 50 yeast, or another genetically traceable organism. Alternatively, candidates for second-site suppressors may be rationally identified by comparing residues lining the ATP-binding 80 pocket ( Figure 1 ). 40 Identification of as-kinase substrates is affected by all six potential limitations. Provision of the as-kinase in excess over its normal expression level may lead to the identification of low affinity, false positive substrates. Depending on the expression of as-alleles on single copy plasmids in cells harbouring a chromosomal deletion of the gene encoding the kinase of interest 51 . This latter approach is not available for mammalian cells, therefore as-kinases have been mostly used in yeast. 22, [52] [53] [54] [55] [56] [57] In mammalian cells, as-kinases have been 5 used to study kinases whose overexpression confers phenotypes. 40, 58 For example, inhibition of the transforming as-kinase v-erbB-as1 with 1NA-PP1 (Scheme 3, R=1-naphthyl, R´= t Bu) inhibited the transforming properties of this kinase. 58 10 Homologous recombination in murine embryonic stem cells can be used to generate mice carrying the as-allele in the chromosomal position of the WT allele. Cell lines, usually embryonic fibroblast lines, can be established from these mice. For differentiated cell types this approach often may not 15 yield sufficient material for biochemical searches for askinase substrates. In addition, generation of these mice is expensive, time-consuming, and laborious. Zinc finger nucleases (ZFNs), which have been designed to bind to and introduce a DNA strand break near a specific DNA sequence, 20 yield frequencies of homologous recombination of 1-20% in yeast, plant, and mammalian cells. 59, 60 Co-transfection of a vector expressing a ZFN and a donor vector providing the cDNA for the as-kinase can be used to integrate the as-allele into upstream exons of the kinase gene. Alternatively, the 25 gatekeeper mutation can be introduced directly into the chromosomal locus.
ATP analogues containing phosphate groups cannot cross the cell membrane because of their charged nature, therefore, substrates are often identified in cell lysates. Permeabilisation 30 of cell membranes with low concentrations of the detergent digitonin is a well-established technique and allows ATP analogues to enter the cell. 61 Permeabilisation conditions can be chosen in such a way as to deplete intracellular ATP concentrations, which is important to ensure that relatively 35 small, possibly micromolar concentrations of the ATP analogue, can successfully compete for the as-kinase against endogenous millimolar concentrations of ATP. Permeabilisation also offers advantages over cell lysis, because cells often exert spatial control over kinases by 40 separating kinase and substrate in separate compartments. Of course, upon lysis this spatial control is lost.
However, significant problems remain with using ATP analogues in cell lysates or permeabilized cells. Cellular ATP, if not efficiently removed, may efficiently compete with 45 precious base-enlarged ATP analogues as phosphate donor, because of its high concentration in cells. Conceptually, ATP can be excluded from the nucleotide binding pocket of an askinase by introducing bulkier amino acids contacting other portions of the adenine system. These secondary mutations are 50 then compensated for by excavating the adenine system. Progress towards these design aims has been made with the development of N 4 -benzyl-5-aminoimidazole-4-carboxamide ribotide triphosphate, which is accepted by an as-kinase, but not by the corresponding WT kinase. 62, 63 55 Hydrolytic release of the -phosphate from ATP analogues such as N 6 -phenylethyl--32 P-ATP, catalysed by apyrases or ATPases, occurs in <1 min. 61 The liberated phosphate can be reincorporated into the cellular ATP pool in <0.1 s, [64] [65] [66] , for example by NDPKs, resulting in label dispersion, and a 60 substantial non-specific background. -S-ATP is resistant to hydrolysis by ATPases and some apyrases, 67 but is a substrate of NDPKs. Not all kinases readily accept -S-ATP as substrate. 44, 48 Thus, further research is required to optimise the performance of ATP analogues to screen for as-kinase 65 substrates.
E Activity-based profiling of active protein kinases
In addition to identifying the physiological roles and substrates of all protein kinases, knowledge about which kinases are active in a given experimental setting, for example 70 cancer cells or after exposure of cells to a stimulus, is also valuable. This latter knowledge can be obtained by using activity-based profiling of kinases 68 by exploiting regulation of the activity of many protein kinases by controlling access of ATP to the ATP binding pocket through movement of the followed by ligation of the activated biotin system to the organic solvent-soluble triethylammonium salt of ATP under anhydrous conditions in dipolar aprotic solvent to form a mixed phosphoric-carboxylic acid anhydride. After labelling, affinity techniques were used to isolate 85 biotin-labelled proteins or peptides for identification and quantification through MS-based techniques. This approach was also used to determine the selectivity of protein kinase inhibitors towards a given protein kinase through competition studies 
Conclusions
5
Examples of genetic and classical approaches towards identification of kinase-substrate pairs were used to illustrate the power and limitations of these approaches. In order to address some of these limitations, chemical genetic approaches have been adopted, and these are currently gaining 10 prominence in the area of kinomics. New developments, particularly with respect to addressing the problems associated with the preparation of nucleotides, should overcome some of the obstacles that limit the application of these approaches at present. The development of new, less 15 disruptive approaches towards delivery of charged nucleotide systems through cell walls will remove a significant limitation to the chemical genetic approach where currently cell permeability limits applications to lysates or other in vitro systems where spatial control over the action of kinases is 20 lost. However, extension to mammalian systems where biomedical targets can be assessed more robustly will truly allow this field of chemical genetics to achieve its full potential. 
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